A Scoping Review of Healthcare Costs for Patients with Cystic Fibrosis

Business & Economics

• Cystic Fibrosis 100%
• Health Care Costs 60%
• General Population 24%
• Costs 17%
• Therapy 11%
• Patient with Cystic Fibrosis 8%
• Drugs 8%
• Chronic Conditions 7%
• Systematic Review 6%
• Incremental Cost 6%
• Life Expectancy 5%
• Data Base 4%
• Health 3%

Medicine & Life Sciences

• Cystic Fibrosis 54%
• Health Care Costs 49%
• Costs and Cost Analysis 28%
• Population 9%
• Drug Approval 6%
• Gray Literature 6%
• Life Expectancy 4%
• Inborn Genetic Diseases 4%
• Economics 3%
• Systematic Reviews 3%
• Therapeutics 3%
• Databases 3%
• Survival 2%
• Health 2%
• Pharmaceutical Preparations 2%

Social Sciences

• Healthcare 42%
• costs 31%
• Improvements in health 6%
• drug 6%
• evidence 5%
• chronic condition 5%
• gray literature 5%
• life expectancy 4%
• management 4%
• cause 2%
• literature 1%
• Group 1%